2020

The company won the "Xinguomen" excellent enterprise in Daxing District.

2019

The company's "3D printing new generation of fully degradable vascular stent" project passed the 2018 Ministry of Industry and Information Technology's scientific and technological achievements assessment

2019

The founder of the company, Dr. Liu Qing, was selected as the "Beijing Model"

2019

The company successfully completed the feasibility clinical trial of 30 cases of "3D printing a new generation of fully degradable coronary drug-eluting stent system"

2019

The company has obtained the approval for the clinical trial of "Fully Degradable Coronary Drug-Eluting Stent System" issued by the State Food and Drug Administration

2018

The company's "Major Technological Breakthrough and Industrialization of Biodegradable Vascular Stent 3D Printing" project has been listed as a key engineering project of high-precision industry by the Beijing Municipal Development and Reform Commission and the Economic and Information Commission; the company has been approved as an academician expert workstation.

2018

The company won the first place in the biomedical field of the 2nd Global Additive Manufacturing Innovation Competition in 2018 and the Innovation Pioneer Award of the competition

2018

The company's "3D printing new generation of fully degradable vascular stent" project passed the 2018 Ministry of Industry and Information Technology's scientific and technological achievements assessment

2018

The company has obtained financial support from the high-precision industry cultivation project in the Zhongguancun Demonstration Zone

2018

The "Biomedical Materials and 3D Printing Medical Device Engineering Research Center" jointly established by the company and the Zhangjiang Research Institute of Fudan University was officially listed

2017

The company won the excellent enterprise of the 6th National Innovation and Entrepreneurship Competition

2017

The company has won the key special project of intergovernmental cooperation in the national key research and development plan

2017

The company won the top ten enterprises of Zhongguancun cutting-edge enterprises in 2017

2017

The company's 3D printing of a new generation of "fully degradable coronary drug-eluting stent system" products has passed the special approval for innovative medical devices

2016

The founder of the company, Dr. Liu Qing, was selected into the National Thousand Talents Program